Evidence map›Paper›PMID 42758231›Full record

ArticleWorld journal of urology2026

Impact of resection bed management on postoperative outcomes after Robot-Assisted Partial Nephrectomy : a retrospective French Nationwide Study (UroCCR 215).

Dimitri Paillusson, Gaëlle Margue, Cécile Champy, Nicolas Doumerc, Pierre Bigot, Franck Bruyere, Philippe Paparel, Louis Surlemont, Jonathan Olivier, Matthieu Durand and 21 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Dimitri PaillussonDepartment of Urology, CHU Nantes, Nantes, France. dimitri.paillusson@chu-nantes.fr.ORCID https://orcid.org/0009-0005-6293-0304
Gaëlle MargueDepartment of Urology, CHU Bordeaux, Bordeaux, France.
Cécile ChampyDepartment of Urology, CIC Henri Mondor - APHP, CHU Henri Mondor - APHP, Créteil, France.
Nicolas DoumercDepartment of Urology, CHU Toulouse, Toulouse, France.
Pierre BigotDepartment of Urology, CHU Angers, Angers, France.
Franck BruyereDepartment of Urology, CHRU Tours, Tours, France.
Philippe PaparelDepartment of Urology, CHU Lyon, Lyon, France.
Louis SurlemontDepartment of Urology, CHU Rouen, Rouen, France.
Jonathan OlivierDepartment of Urology, CHU Lille, Lille, France.
Matthieu DurandDepartment of Urology, CHU Nice, Nice, France.
Nicolas BrangerDepartment of Urology, Institut Paoli Calmettes, Marseille, France.
Thibaut WaeckelDepartment of Urology, CHU Caen, Caen, France.
Alexis FontenilDepartment of Urology, CHU Nîmes, Nîmes, France.
Maxime ValleeDepartment of Urology, CHU Poitiers, Poitiers, France.
Idir OuzaidDepartment of Urology, Hôpital Bichat - APHP, Paris, France.
Jean-Jacques PatardDepartment of Urology, CH Mont-de-Marsan, Mont-de-Marsan, CH, France.
Julien GuillotreauDepartment of Urology, Clinique Pasteur, Toulouse, France.
Frédéric PanthierDepartment of Urology, Hôpital Tenon - APHP, Paris, France.
Olivier BelasDepartment of Urology, Pôle Santé Sud, Le Mans, France.
Romain BoissierDepartment of Urology,, CHU La Conception - APHM, Marseille, France.
Fayek TahaDepartment of Urology, CHU Reims, Reims, France.
Nicolas LetangDepartment of Urology, Médipôle St Roch - Polyclinique Cabestany, Cabestany, France.
Bastien ParierDepartment of Urology, Hôpital Bicêtre - APHP, Le Kremlin-Bicêtre, France.
Hervé LangDepartment of Urology, CHU Strasbourg, Strasbourg, France.
Constance DameronDepartment of Urology, Hôpital Européen Georges Pompidou - APHP, Paris, France.
Grégory VerhoestDepartment of Urology, CHU Rennes, Rennes, France.
Clément SarrazinDepartment of Urology, CHU Grenoble Alpes, Grenoble, France.
Jean-Christophe BernhardDepartment of Urology, CHU Bordeaux, Bordeaux, France.
Soline BobetClinique Des Données, CHU Nantes, Nantes, France.
Mathilde KarakachoffClinique Des Données, CHU Nantes, Nantes, France.
Stéphane de VergieDepartment of Urology, CHU Nantes, Nantes, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionKidney cancer remains a significant public health issue, mainly treated by surgery for localized tumors. RAPN is increasingly adopted due to its nephron-sparing advantage, yet optimal management of the renal resection bed remains controversial. Various techniques including parenchymal and/or capsular sutures or sutureless approaches, with or without adjunctive hemostatic agents (HA), are used, but their comparative safety and efficacy are not well established. MATERIALS AND

methodsThis retrospective study analyzed data from 5,250 patients who underwent first RAPN in 26 centres, extracted from national UroCCR database. Patients were categorized into eight groups based on resection bed management techniques, with the main groups being double-layer sutures (DLS) and parenchymal sutures, with or without HA. Postoperative complications were classified using the Clavien-Dindo system. Multivariate logistic regression was performed adjusting for key confounders including age, sex, BMI, ASA score, RENAL-score, and preoperative creatinine. Secondary outcomes included length of hospital stay and comparison of HA use within suture and sutureless groups.

resultsIntraoperative complications were rare (3.9%). Postoperative complications occurred in 19.1% of patients, with 3.1% experiencing severe complications (≥ grade 3). The "Sutureless without HA" group had a significantly higher rate of perioperative transfusions in multivariate analysis (17.8% vs. 6.8%; adjusted OR 3.3), although this did not translate into increased reinterventions or perirenal hematomas. No significant differences were found between groups regarding infectious or length of stay. Vascular complications were lower in "DLS with HA". The use of HA in sutureless groups was associated with shorter operative times and reduced transfusion rates, and no difference was observed in suture groups.

conclusionIn this large, multicenter cohort, various hemostatic techniques during RAPN showed overall comparable safety profiles, except for a higher transfusion rate associated with sutureless without HA approaches, and a protective effect on vascular complications of DLS with HA.

Indexed as

Kidney NeoplasmsNephrectomyPostoperative ComplicationsRobotic Surgical ProceduresAgedFemaleFranceHumansLength of StayMaleMiddle AgedRetrospective StudiesSuture TechniquesTreatment OutcomeKidney cancerPartial nephrectomyPostoperative complicationsRobot assisted partial nephrectomy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.